metsera glp-1 Metsera's long-acting looks competitive in Phase 2 obesity study Pfizer's Metsera GLP-1 hits mark

High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial

Mechanism: GLP-1 receptor agonist

Haque SM, Rahman H, Rahman N, Azmi SN, Ashwaq O, Wabaidur SM, Siddiqui MR, Alam M (2023) Application of Box-Behnken design combined response surface methodology to optimize HPLC and spectrophotometric techniques for quantifying febuxostat in pharmaceutical formulations and spiked wastewater samples

DOI: Published: Publisher Name: Springer, Cham Print ISBN: 978-3-030-67726-8 Online ISBN: 978-3-030-67727-5 eBook Packages: MedicineMedicine (R0)

In Davila's experience, the best outcomes happen when stopping is treated as a planned transition rather than an abrupt finish, with sustainable habits around eating, movement and stress already in place